MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Phase 2
Recruiting
- Conditions
- Acquired Amegakaryocytic ThrombocytopeniaAcquired Pure Red Cell AplasiaSevere Aplastic AnemiaParoxysmal Nocturnal Hemoglobinuria
- Interventions
- Radiation: Total Body IrradiationBiological: Cell InfusionDrug: Post-Transplant G-CSF
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 60
- Registration Number
- NCT06412497
- Locations
- 🇺🇸
University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
Phase 2
Recruiting
- Conditions
- Pancreatic NeoplasmDuodenal Neoplasm
- Interventions
- Other: Medical Chart ReviewOther: Questionnaire AdministrationProcedure: Ultrasound ImagingDrug: Thoracic Epidural AnalgesiaProcedure: X-Ray Imaging
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 78
- Registration Number
- NCT06411795
- Locations
- 🇺🇸
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
Phase 2
Recruiting
- Conditions
- Classic Hodgkin LymphomaAutologous Stem Cell Transplant
- Interventions
- Procedure: Autologous stem cell transplant
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 28
- Registration Number
- NCT06377540
- Locations
- 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Phase 1
Recruiting
- Conditions
- Gynecologic CancerOvarian CancerFallopian Tube CancerPrimary Peritoneal Cavity Cancer
- Interventions
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 33
- Registration Number
- NCT06342986
- Locations
- 🇺🇸
University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
Not Applicable
Recruiting
- Conditions
- Tobacco UseNicotine DependenceCigarette Smoking
- Interventions
- Other: Cigarettes
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 30
- Registration Number
- NCT06295757
- Locations
- 🇺🇸
Irina Stepanov, PhD, Minneapolis, Minnesota, United States
Effect of Kava on Anxiety and Stress in Cancer Survivors
Early Phase 1
Recruiting
- Conditions
- AnxietyStressSleepKavaCancerDepression
- Interventions
- Dietary Supplement: Placebo
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 43
- Registration Number
- NCT06213298
- Locations
- 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States
MT2022-01: MSCs for ALD
Phase 1
Recruiting
- Conditions
- Cerebral Adrenoleukodystrophy
- Interventions
- Biological: Mesenchymal stem cells (IV-MSC)
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 10
- Registration Number
- NCT06030648
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Role of Acetaldehyde in the Development of Oral Cancer
Not Applicable
Recruiting
- Conditions
- Fanconi AnemiaAlcohol-Related CarcinomaOral Cavity Carcinoma
- Interventions
- First Posted Date
- 2023-08-03
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 170
- Registration Number
- NCT05973656
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
Not Applicable
Completed
- Conditions
- Chemotherapeutic ToxicityOncologyMetastatic Solid Tumor
- Interventions
- Other: Oncology ConsultationOther: Chemotherapy toxicity tool
- First Posted Date
- 2023-04-12
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 34
- Registration Number
- NCT05809557
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Allo HSCT Using RIC and PTCy for Hematological Diseases
Phase 2
Recruiting
- Conditions
- Plasma Cell LeukemiaBiphenotypic Acute LeukemiaProlymphocytic LeukemiaLeukemia, MyeloidAcute Lymphocytic LeukemiaChronic Myelogenous LeukemiaMyelodysplastic SyndromesAcute Myelogenous LeukemiaUndifferentiated LeukemiaMyelodysplastic Syndrome With Excess Blasts-1
- Interventions
- Biological: Peripheral Blood Stem Cell TransplantBiological: Bone Marrow Cell TransplantRadiation: Total Body Irradiation
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 56
- Registration Number
- NCT05805605
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath